A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices

Inclusion Criteria: * Male adults of age of 18-45 years. * Measles immune, as determined by IgG antibody levels. * Healthy as supported by medical history, physical examination and laboratory evaluation on preset parameters. * Signed informed consent for participation in trial and for HIV screening. Exclusion Criteria: * Medical history of immunodeficiency/suppression or subject with history of close contact with immunocompromised/ immunosuppressed person. * Chronic administration of immunosuppressants or other immune modifying agents * Acute febrile illness or suspected measles illness or acute infectious disease * Acute or chronic, clinically significant pulmonary, endocrine, autoimmune, psychiatric, cardiovascular, neurological, hepatic or renal functional abnormality which in the opinion of the investigator, might interfere with the study objectives * History of seizure disorders * Major congenital defects * Thrombocytopenia or known bleeding disorders 8. History of a previous severe allergic reaction * Positive serology for HIV antibody, HCV antibody or Hepatitis B surface antigen * Known hypersensitivity to any component of the study vaccine